The trademark application was filed by Opella Healthcare Group SAS, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on June 8, 2023, and it was registered by office on September 15, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).